Literature DB >> 5804361

Prophylaxis of smallpox with methisazone.

D J Bauer, L St Vincent, C H Kempe, P A Young, A W Downie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5804361     DOI： 10.1093/oxfordjournals.aje.a121057

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  17 in total

Review 1.  The contribution of virology to contemporary medicine.

Authors:  C Stuart-Harris
Journal:  Br J Prev Soc Med       Date:  1975-03

2.  Advances in antiviral chemotherapy.

Authors:  R A Buchanan
Journal:  Can Med Assoc J       Date:  1979-01-06       Impact factor: 8.262

Review 3.  Antiviral chemotherapy: the first decade.

Authors:  D J Bauer
Journal:  Br Med J       Date:  1973-08-04

Review 4.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1970-05       Impact factor: 2.401

5.  For and against smallpox vaccination.

Authors: 
Journal:  Br Med J       Date:  1970-05-09

6.  Letter: Vaccination of smallpox contacts.

Authors:  D J Bauer
Journal:  Br Med J       Date:  1974-03-23

7.  Success and failure in human virus diseases. 3. Chemotherapy.

Authors:  C Stuart-Harris
Journal:  Br Med J       Date:  1971-02-13

8.  Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.

Authors:  Erica N Parker; Jiangli Song; G D Kishore Kumar; Samuel O Odutola; Gustavo E Chavarria; Amanda K Charlton-Sevcik; Tracy E Strecker; Ashleigh L Barnes; Dhivya R Sudhan; Thomas R Wittenborn; Dietmar W Siemann; Michael R Horsman; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2015-09-25       Impact factor: 3.641

Review 9.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

10.  Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.

Authors:  M N Ellis; D C Lobe; T Spector
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.